Portolan Capital Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,553
Closed -$851K 129
2025
Q1
$851K Sell
34,553
-170,812
-83% -$4.22M 0.06% 103
2024
Q4
$4.76M Sell
205,365
-102,734
-33% -$2.57M 0.32% 93
2024
Q3
$8.35M Buy
308,099
+122,770
+66% +$3.72M 0.61% 58
2024
Q2
$5.33M Buy
+185,329
New +$5.68M 0.44% 80

Other funds holding KIDS

Portolan Capital Management's KIDS Position: Q2 2025 in Review

Portolan Capital Management sold out of OrthoPediatrics (KIDS) in Q2 2025, closing a stake of 34,553 shares — an estimated $851K sold.

Portolan Capital Management first reported a position in KIDS in Q2 2024 and held it in 4 quarters. The position peaked at $8.35M in Q3 2024. 117 funds tracked by Wall St. Rank hold KIDS as of Q2 2025.

  • Portolan Capital Management reported no remaining OrthoPediatrics position as of Q2 2025 after selling out during the quarter.
  • Portolan Capital Management sold 34,553 OrthoPediatrics shares in Q2 2025, an estimated $851K.
  • Portolan Capital Management first reported a position in OrthoPediatrics in Q2 2024 and held it in 4 quarters.
  • Portolan Capital Management's OrthoPediatrics position peaked at $8.35M in Q3 2024.
  • 117 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2025.

Based on Portolan Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.